Salvage radiation in men after prostate-specific antigen failure and the risk of death
β Scribed by Shane E. Cotter; Ming Hui Chen; Judd W. Moul; W. Robert Lee; Bridget F. Koontz; Mitchell S. Anscher; Cary N. Robertson; Philip J. Walther; Thomas J. Polascik; Anthony V. D'Amico
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 139 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O
## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostateβspecific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio